Search Results 841-850 of 17008 for citrulline loading phase

  1. Gastroenterology and Hepatology - Clinical trials

    This is a phase II multi-center study of nab-paclitaxel, gemcitabine and cisplatin (NGC triple regimen) as preoperative therapy in potentially resectable ...

  2. A Study of Oral Ozanimod as Maintenance Therapy for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  3. Neurology - Clinical trials

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

  4. Clinical trials - Oncology (Medical)

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

  5. Clinical trials - Oncology (Medical)

    This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...

  6. Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations - Mayo Clinic

    ... (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that ... load must be less than 2000 IU/mL (104 copies/mL) prior to the first dose of study ...

  7. Gastroenterology and Hepatology - Clinical trials

    The primary purpose of the phase II study is to estimate the progression-free survival rate at 2 years post-registration to see if treatment is efficacious ...

  8. Claudication - Symptoms & causes - Mayo Clinic

    Signs or symptoms of peripheral artery disease, usually in more-advanced stages, include: Cool skin; Severe, constant pain that progresses to numbness; Skin ...

  9. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... HIV-infected patients should be monitored every 12 weeks for viral load and CD4 ...